A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP
Clinical trial NCT03466073 · COMPLETED
Trial details
- NCT number
- NCT03466073
- Sponsor
- BioAegis Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-28
- Primary completion
- 2019-04-02
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.